Angelique L. Rops

2.8k citations

43 papers · 2.0k indexed · h-index 26

Nephrology top 0.5%
- Renal Diseases and Glomerulopathies 10
- Chronic Kidney Disease and Diabetes 5
Critical Care and Intensive Care Medicine top 2%
- Trauma, Hemostasis, Coagulopathy, Resuscitation 4
Cell Biology top 2%
- Proteoglycans and glycosaminoglycans research 23
Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 13
Hematology top 5%
- Platelet Disorders and Treatments 19
Molecular Biology
- Glycosylation and Glycoproteins Research 11
Immunology
- Complement system in diseases 4

Co-authors: Johan van der Vlag Jo H. M. Berden Toin H. Van Kuppevelt Ton J. Rabelink Joost F.M. Lensen Tessa J.M. Wijnhoven Marjolein Garsen M.J. van den Hoven
Cited by: Nephrology Critical Care and Intensive Care Medicine Cell Biology
Journals: Journal of Biological Chemistry (3 papers)The Journal of Immunology (2 papers)PLoS ONE (5 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Angelique L. Rops

43 papers receiving 2.0k citations

Peers

Countries citing papers authored by Angelique L. Rops

Since Specialization

Citations

This map shows the geographic impact of Angelique L. Rops's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelique L. Rops with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelique L. Rops more than expected).

Fields of papers citing papers by Angelique L. Rops

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelique L. Rops. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelique L. Rops. The network helps show where Angelique L. Rops may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Angelique L. Rops, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Angelique L. Rops Line = papers co-authored together Angelique L. Rops links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Glomerular endothelial glycocalyx-derived heparan sulfate inhibits glomerular leukocyte influx and attenuates experimental glomerulonephritis Frontiers in Molecular Biosciences ·Marissa L. Maciej-Hulme,Jasper J. van Gemst,Patience Sanderson,Angelique L. Rops,Jo H. M. Berden,Bart Smeets,I. Jonathan Amster,Ton J. Rabelink,Johan van der Vlag	2023	2
2	Blocking of inflammatory heparan sulfate domains by specific antibodies is not protective in experimental glomerulonephritis PLoS ONE ·Jasper J. van Gemst,Nathalie J. H. G. Passmann,Angelique L. Rops,Toin H. Van Kuppevelt,Jo H. M. Berden,Markus A. Loeven,Ton J. Rabelink,Bart Smeets,Johan van der Vlag	2021	2
3	Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains PLoS ONE ·Jasper J. van Gemst,M. Kouwenberg,Angelique L. Rops,Toin H. Van Kuppevelt,Jo H. M. Berden,Ton J. Rabelink,Markus A. Loeven,Johan van der Vlag	2018	12
4	Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice Kidney International ·Angelique L. Rops,Erik W.L. Jansen,Alie van der Schaaf,Elmar Pieterse,Nils Rother,Julia M. Hofstra,Henry Dijkman,Anne-Els van de Logt,Jack F.M. Wetzels,Johan van der Vlag,Annemiek B. van Spriel	2018	30
5	Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis American Journal Of Pathology ·Marjolein Garsen,Marilen Benner,Henry Dijkman,Toin H. Van Kuppevelt,Jin‐Ping Li,Ton J. Rabelink,Israël Vlodavsky,Jo H. M. Berden,Angelique L. Rops,Michael Elkin,Johan van der Vlag	2016	51
6	Cathepsin L is crucial for the development of early experimental diabetic nephropathy Kidney International ·Marjolein Garsen,Angelique L. Rops,Henry Dijkman,Brigith Willemsen,Toin H. Van Kuppevelt,Frans G. M. Rüssel,Ton J. Rabelink,Jo H. M. Berden,Thomas Reinheckel,Johan van der Vlag	2016	52
7	Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte The Journal of Pathology ·Marjolein Garsen,Ramon Sonneveld,Angelique L. Rops,Suzanne Huntink,Toin H. Van Kuppevelt,Ton J. Rabelink,Joost G.J. Hoenderop,Jo H. M. Berden,Tom Nijenhuis,Johan van der Vlag	2015	38
8	The role of heparan sulfate as determining pathogenic factor in complement factor H-associated diseases Molecular Immunology ·Markus A. Loeven,Angelique L. Rops,Jo H. M. Berden,Mohamed R. Daha,Ton J. Rabelink,Johan van der Vlag	2014	22
9	Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis Kidney International ·Angelique L. Rops,Markus A. Loeven,Jasper J. van Gemst,Iris Eversen,Xander M. van Wijk,Henry Dijkman,Toin H. Van Kuppevelt,Jo H. M. Berden,Ton J. Rabelink,Jeffrey D. Esko,Johan van der Vlag	2014	43
10	Protein-Bound Uremic Toxins Stimulate Crosstalk between Leukocytes and Vessel Wall Journal of the American Society of Nephrology ·Anneleen Pletinck,Griet Glorieux,Eva Schepers,Gerald Cohen,B. Gondouin,Maria Van Landschoot,Sunny Eloot,Angelique L. Rops,Johan Van de Voorde,An S. De Vriese,Johan van der Vlag,Philippe Brunet,Wim Van Biesen,Raymond Vanholder	2013	88
11	The Heparan Sulfate Motif (GlcNS6S-IdoA2S)3, Common in Heparin, Has a Strict Topography and Is Involved in Cell Behavior and Disease Journal of Biological Chemistry ·Nicole C. Smits,Sindhulakshmi Kurup,Angelique L. Rops,Gerdy B. ten Dam,Leon F.A.G. Massuger,Theo Hafmans,Jeremy E. Turnbull,Dorothe Spillmann,Jin-Ping Li,Stephen J. Kennel,Jonathan S. Wall,Nicholas W. Shworak,P. N. Richard Dekhuijzen,Johan van der Vlag,Toin H. Van Kuppevelt	2010	49
12	The Tetraspanin CD37 Protects Against Glomerular IgA Deposition and Renal Pathology American Journal Of Pathology ·Angelique L. Rops,Carl G. Figdor,Alie van der Schaaf,Wim P.M. Tamboer,Marinka A.H. Bakker,Jo H. M. Berden,Henry Dijkman,Eric J. Steenbergen,Johan van der Vlag,Annemiek B. van Spriel	2010	13
13	Role of the Heparan Sulfate Proteoglycan Syndecan-1 (CD138) in Delayed-Type Hypersensitivity The Journal of Immunology ·Behzad Kharabi Masouleh,Gerdy B. ten Dam,Martin K. Wild,Ruth Seelige,Johan van der Vlag,Angelique L. Rops,Frank Echtermeyer,Dietmar Vestweber,Toin H. Van Kuppevelt,Ludwig Kiesel,Martin Götte	2009	49
14	Anti-proteinuric effects of glycosaminoglycan-based drugs. PubMed ·Tessa J.M. Wijnhoven,Joost F.M. Lensen,Angelique L. Rops,Kevin McCarthy,Johan van der Vlag,Jo H. M. Berden,Lambert P.W.J. van den Heuvel,Toin H. Van Kuppevelt	2007	15
15	Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains Nephrology Dialysis Transplantation ·T. J. Wijnhoven,Joyce Geelen,Marinka A.H. Bakker,Joost F.M. Lensen,Angelique L. Rops,Andrea B. Kramer,G. Navis,M. J. W. van den Hoven,Johan van der Vlag,Jo H. M. Berden,Jack F.M. Wetzels,Lambert P.W.J. van den Heuvel,L.A.H. Monnens,Toin H. Van Kuppevelt	2007	7
16	Heparanase in glomerular diseases Kidney International ·M.J. van den Hoven,Angelique L. Rops,Israël Vlodavsky,Vicki Levidiotis,Jo H. M. Berden,Johan van der Vlag	2007	97
17	Induction of Glomerular Heparanase Expression in Rats with Adriamycin Nephropathy Is Regulated by Reactive Oxygen Species and the Renin-Angiotensin System Journal of the American Society of Nephrology ·Andrea B. Kramer,Mabel van den Hoven,Angelique L. Rops,Tessa J.M. Wijnhoven,Lambert van den Heuvel,Joost F.M. Lensen,Toin van Kuppevelt,Harry van Goor,Johan van der Vlag,Gerjan Navis,Jo H. M. Berden	2006	72
18	Aberrant Heparan Sulfate Profile in the Human Diabetic Kidney Offers New Clues for Therapeutic Glycomimetics American Journal of Kidney Diseases ·Tessa J.M. Wijnhoven,Joost F.M. Lensen,Angelique L. Rops,Johan van der Vlag,Svein O. Kolset,Hans‐Jacob Bangstad,Per Pfeffer,M. J. W. van den Hoven,Jo H. M. Berden,Lambert P.W.J. van den Heuvel,Toin H. Van Kuppevelt	2006	32
19	Increased expression of heparanase in overt diabetic nephropathy Kidney International ·M.J. van den Hoven,Angelique L. Rops,Marinka A.H. Bakker,Jan Aten,Niels W. Rutjes,Peggy Roestenberg,Roel Goldschmeding,Eyal Zcharia,Israël Vlodavsky,Johan van der Vlag,Jo H. M. Berden	2006	108
20	Isolation and characterization of conditionally immortalized mouse glomerular endothelial cell lines Kidney International ·Angelique L. Rops,Johan van der Vlag,Cor Jacobs,Henry Dijkman,Joost F.M. Lensen,Tessa J.M. Wijnhoven,Lambert P. van den Heuvel,Toin H. Van Kuppevelt,Jo H. M. Berden	2004	67

About Angelique L. Rops

Angelique L. Rops is a scholar working on Immunology and Allergy, Nephrology and Hematology, having authored 43 papers that have together received 2.0k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (23 papers), Platelet Disorders and Treatments (19 papers), Cell Adhesion Molecules Research (13 papers), Glycosylation and Glycoproteins Research (11 papers), Renal Diseases and Glomerulopathies (10 papers), Chronic Kidney Disease and Diabetes (5 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (4 papers) and Complement system in diseases (4 papers). The work is most often cited by research in Nephrology (739 citations), Critical Care and Intensive Care Medicine (240 citations) and Cell Biology (677 citations). Angelique L. Rops has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Johan van der Vlag, Jo H. M. Berden, Toin H. Van Kuppevelt, Ton J. Rabelink, Joost F.M. Lensen, Tessa J.M. Wijnhoven, Marjolein Garsen, M.J. van den Hoven, Henry Dijkman and Israël Vlodavsky. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact